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The Use of Human Sweat Gland–Derived Stem Cells
for Enhancing Vascularization during Dermal
Regeneration
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Ann K. Reckhenrich3, Caroline Weber1, Thilo L. Schenck3, Tim Becker1, Charli Kruse1,
Hans-Gu¨nther Machens3 and Jose´ T. Egan˜a3,4
Vascularization is a key process in tissue engineering and regeneration and represents one of the most
important issues in the field of regenerative medicine. Thus, several strategies to improve vascularization are
currently under clinical evaluation. In this study, stem cells derived from human sweat glands were isolated,
characterized, seeded in collagen scaffolds, and engrafted in a mouse full skin defect model for dermal
regeneration. Results showed that these cells exhibit high proliferation rates and express stem cell and
differentiation markers. Moreover, cells responded to angiogenic environments by increasing their migration
(Po0.001) and proliferation (Po0.05) capacity and forming capillary-like structures. After seeding in the
scaffolds, cells distributed homogeneously, interacting directly with the scaffold, and released bioactive
molecules involved in angiogenesis, immune response, and tissue remodeling. In vivo, scaffolds containing
cells were used to induce dermal regeneration. Here we have found that the presence of the cells significantly
improved vascularization (Po0.001). As autologous sweat gland–derived stem cells are easy to obtain, exhibit a
good proliferation capacity, and improve vascularization during dermal regeneration, we suggest that the
combined use of sweat gland–derived stem cells and scaffolds for dermal regeneration might improve dermal
regeneration in future clinical settings.
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INTRODUCTION
Skin defects represent a severe problem in modern societies.
Among several kinds of defects, chronic ulcers have a
tremendous economical impact, and only in the United
States costs related to wound care arise to billions of dollars
per year (Mustoe et al., 2006). More importantly, chronic
ulcers significantly affect patients’ quality of life. For instance,
diabetic chronic ulcers cause more than 60% of the non-
traumatic lower limb amputations (Driver et al., 2010).
Other conditions such as surgical wounds or burn injuries
also require special wound care. Although the current
clinical gold standard is the defect coverage through trans-
plantation of autologous skin grafts, several complications are
associated with this procedure. Donor site morbidity, graft
rejection, and limited availability of donor tissue are among
the most common problems (Geary and Tiernan, 2009;
Boudana et al., 2010). As an alternative to skin graft trans-
plantations, tissue engineering has emerged as a therapeutic
option (Rizzi et al., 2010).
Most tissue engineering approaches rely on the vascu-
larization capacity of the engrafted structures (Kaully et al.,
2009). In fact, in the absence of blood vessels, engineered
tissue cannot be perfused with oxygen, nutrients, and cells
involved in the regenerative process (Papavasiliou et al.,
2010). As a consequence of such low perfusion, high
infection rates and low regeneration are general problems
in the field of tissue engineering (Zhong et al., 2010). Thus,
the development of new strategies to enhance vasculariza-
tion is a major issue in regenerative medicine. Recent
approaches targeting the modification of scaffolds by the
use of recombinant molecules or DNA vectors have
been tried (Reckhenrich et al., 2011). Furthermore, the
development of pre-vascularized scaffolds with artificial
or native blood vessels is another promising approach
in the field (Unger et al., 2010). Finally, cellular technol-
ogies using genetically modified cells or stem cells have
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been evaluated in clinical and preclinical trials (Powell
et al., 2010; Wang et al., 2010; Lu¨ et al., 2012; Zhang
et al., 2011).
Previously, we have shown that human stem cells derived
from salivary glands and pancreas reveal common character-
istics and similar growth and multipotent differentiation
capabilities (Gorjup et al., 2009). These cells are character-
ized by the expression of the intermediate filament Nestin,
which has been described to be associated with the stemness
or multipotency (Atari et al., 2011; Wiese et al., 2004). We
have also shown that mouse stem cells derived from salivary
glands and pancreas improved vascularization during skin
regeneration (Egan˜a et al., 2009a). A drawback of this
approach is that, in clinical settings, such tissue samples are
difficult, if not impossible, to obtain. Moreover, as in the
former study, gland-derived stem cells were isolated from
murine tissue; the regenerative potential of stem cells derived
from human glands still remains unknown.
In search of an easily accessible tissue to isolate auto-
logous stem cells without harming the patient, we examined
the skin and have found that Nestin-expressing cells are
located in the hair follicles and sweat glands (Tiede et al.,
2009). In culture, these cells display long-term proliferation, a
broad differentiation capacity, and nearly 80% express Nestin
(Petschnik et al., 2010). To study the regenerative potential of
human sweat gland–derived stem cells (SGSCs), we evaluate
whether cell-seeded scaffolds improve vascularization during
dermal regeneration.
RESULTS
Stem cell characterization
SGSCs were isolated, seeded in DMEM-10, and charac-
terized. Here we found that cells adhere to polystyrene,
showing fibroblast-like morphology (Figure 1a) and a high
proliferation rate with a doubling time of about 4.3 days
(Figure 1b). To determine the expression of stem cell markers
and to evaluate their multilineage differentiation potential
in vitro, immunocytochemistry was performed. Results
showed that SGSCs express Oct4, Nestin, and Nanog
(Figure 1c). Furthermore, reverse-transcriptase–PCR showed
the expression of stem cell and differentiation markers. Here
we found that, in addition to Oct4, Nestin, and Nanog,
SGSCs also express the stem cell markers Sox2, Klf4, and
cMyc. Furthermore, we have found that cells also expressed
the proliferation marker Ki67, and because of their sponta-
neous differentiation in vitro, we detected transcripts of
cells derived from the ectoderm (b3T, PGP9.5, NF, S100),
mesoderm (a-smooth muscle actin, PPARg, Runx2), and
endoderm (albumin, amylase, vWF) (Figure 1d). Next, the
functional effects of pro-angiogenic environments on the
behavior of SGSC were evaluated. Here we have found that
when cells were seeded on Matrigel-coated surfaces, they
acquire an endothelial-like behavior, thus forming capillary-
like structures in DMEM-10 and endothelial growth medium
(EGM) (Figure 2a). Further, we have also found that EGM
increased cell migration, evaluated in a scratch assay (Figure
2b; Po0.001), and induced cell proliferation (Figure 2c;
Po0.05).
Cell seeding in the scaffold
After seeding in the scaffolds, cells were stained and analyzed
by confocal microscopy. Here, homogeneous distribution
and direct attachment of the cells to the collagen scaffold
were observed (Figure 3a). Subsequently, viability of the
SGSCs was determined by metabolic 3-(4,5-dimethyl-
2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)
assays. Results showed that in the presence of MTT, scaffolds
containing cells become dark blue. As shown in Figure 3b,
such color was homogeneously distributed and shows that
cells were metabolically active in all areas of the scaffold for
at least 14 days after seeding. Moreover, a significant increase
in metabolic activity from day 1 to day 14 suggests cell
proliferation in the scaffold (Po0.05). To evaluate the release
of bioactive molecules from cell-seeded scaffolds, a cytokine
array profile was performed. Results showed that scaffolds
containing cells were able to release several bioactive
molecules, which are involved in key processes for tissue
regeneration such as angiogenesis, immune response, and
tissue remodeling. Here we detect the presence of PAI-1,
MMP-9, TIMP-1, pentraxin 3, TSP-1, uPA, VEGF, CD26,
angiopoietin, IGFBP-3, and IL-8 (Figure 3c). The following
molecules were either not detected or detected in very low
levels: activin A, ADAMTS-1, angiopoietin 1, angiopoietin 2,
angiostatin, amphiregulin, artemin, coagulation factor III,
CXCL16, EGF, EG-VEGF, endoglin, endostatin, endothelin-1,
FGF acidic, FGF basic, FGF-4, FGF-7, GDNF, GM-CSF, HB-
EGF, HGF, IGFBP-1, IGFBP-2, IL-1b, TGF-b1, leptin, MCP-1,
MIP-1a, MMP-8, NRG1-b1, PD-ECGF, PDGF-AA, PDGF-BB/
AB, persephin, CXCL4, PlGF, prolactin, serpin B5, serpin F1,
TIMP-4, TSP-2, vasohibin, and VEGF-C.
Induction of vascularization in vivo
After confirming that SGSCs can be used to bioactivate
scaffolds for dermal regeneration, scaffolds were engrafted
in an in vivo full skin defect model (Figure 4). Here, scaffolds
containing cells were well tolerated by the animals, and
no evident side effects were observed in either group. To
quantify the influence of SGSCs in the vascularization
process, animals were killed 2 weeks after engraftment, and
the whole skin from the back, including the scaffolds, was
removed. Afterwards, vascularization levels were quantified
by tissue transillumination and digital segmentation. Com-
pared with controls (non-seeded scaffolds), a much more
widespread vascular network throughout the whole scaffold
was observed in the presence of SGSCs (Figure 5a).
Quantification of the vascularized area showed significant
differences between cell-seeded scaffolds and the control
group (Figure 5a; Po0.001), with values of 62.28±8.6%
for control and 95.6±10% (mean±standard error of mean
(SEM); n¼8) for the scaffolds containing SGSCs. Thereafter,
scaffolds were subjected to histological analysis, and
their general structure and cellularity level were evaluated
(Figure 5b). Here we found that the tissue directly beneath the
scaffold was significantly thicker in the group containing
SGSCs (Figure 5b; Po0.005). Unexpectedly, the presence
of SGSCs decreased the cellularity levels of the scaffold
(Figure 5b; Po0.001).
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DISCUSSION
Cell-seeded scaffolds have been successfully used in several
fields of tissue engineering, including bone, cartilage, and
nerve (Hurtado et al., 2006; Shangkai et al., 2007; Yoon
et al., 2007). Studies have also been conducted in the field of
skin tissue engineering, and have shown promising results
(Dieckmann et al., 2010).
Previous evidence showed that keratinocytes and fibro-
blasts can be cultured in Integra matrix in vitro (Ojeh et al.,
2001). Similarly, our results show that human SGSCs can also
be seeded in collagen scaffolds (Figure 3). To our knowledge,
this stem cell source is previously unreported, representing
a promising cell source for activating scaffolds for tissue
regeneration. Previous results showed that autologous cells
were more effective than heterologous cells in scaffold bio-
activation for dermal regeneration (Hollander et al., 1999;
Wisser and Steffes, 2003). Here we show that SGSCs are easy
to isolate, giving rise to an adherent cell population that can
be robustly expanded ex vivo (Figure 1b), allowing one to
obtain therapeutic numbers of autologous cells in clinical
time frames.
In this study, we have demonstrated that SGSCs improve
vascularization during scaffold-dependent dermal regenera-
tion in a bilateral full skin defect in vivo (Figure 5a). We have
shown that SGSCs responded to pro-angiogenic environ-
ments, increasing their proliferation and migration capacity
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Figure 1. Characterization of sweat gland–derived stem cells. (a) Cells were isolated and characterized in terms of morphology, (b) proliferation capacity,
and (c) the presence of the stem cell markers Oct4, Nestin, and Nanog, all counterstained with 40,6-diamidino-2-phenylindole (DAPI). (d) Reverse-
transcriptase–PCR (RT-PCR) analysis showed the expression of the stem cell markers Nestin, Nanog, Oct4, Sox2, KIf4, and cMyc. Furthermore, cells expressed
the proliferation marker Ki67 and differentiation markers of cells derived from the ectoderm (b3T, PGP9.5, NF, and S100), mesoderm (aSMA, PPARg,
and Runx2), and endoderm (albumin, amylase, and vWF). Bar¼100 mm.
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and forming capillary-like structures (Figure 2). In addition,
we have found that SGSCs express the endothelial markers
von Willebrand factor and a-smooth muscle actin (Figure 1d).
These data support the hypothesis that SGSCs may improve
tissue regeneration by direct differentiation into vessel-related
cells (e.g., endothelial cells).
As an alternative mechanism of contribution, SGSCs
may also act as trophic mediators, rather than by direct cell
differentiation, thus helping to create a pro-regenerative
microenvironment in the wound area. This concept has been
clearly established before for other stem cell populations
such as mesenchymal stem cells, which may contribute to
tissue regeneration by releasing chemotactic, immunomodu-
latory, and pro-angiogenic factors (Caplan and Dennis,
2006). We have previously shown that the release of
angiogenic factors from cell-seeded scaffolds might
enhance angiogenesis, independently of cell differentiation
(Egan˜a et al., 2009b). Here, our results showed that, in
contrast to control scaffolds (data not shown), SGSC-seeded
scaffolds release at least 11 bioactive molecules (Figure 3c).
Among them, angiogenin and VEGF are particularly
important because it has been described that both mole-
cules have a direct effect on angiogenesis (Distler et al.,
2003). The release of the chemokine IL-8 and the factor
pentraxin 3 suggests that SGSC might also have an immuno-
modulatory role during tissue regeneration. Finally, the
release of the metalloproteinase MMP-9 and the metallo-
proteinase inhibitor TIMP-1 might have a role later on in the
process of tissue remodeling, a key step in wound healing
(Yang et al., 2009).
High biocompatibility between SGSCs and the collagen
scaffold suggests that SGSC-seeded scaffolds may represent
a constant source for releasing bioactive molecules during
wound healing (Figure 3). In this context, further experiments
have to be conducted to determine the full spectrum of
molecules with regenerative potential that are released from
SGSC-seeded scaffolds, and the influence of these molecules
on tissue regeneration. In addition, more work needs to be
carried out to compare this new technology with results
obtainable with other primary cells such as fibroblasts or
mesenchymal stem cells.
MATERIALS AND METHODS
Cell isolation
Human SGSCs were obtained as we described before (Petschnik
et al., 2010). Briefly, under a light microscope, sweat glands were
mechanically isolated from a predigested and dissociated axillary
skin biopsy. Subsequently, sweat glands and outgrowing cells were
cultured in DMEM supplemented with 20% fetal calf serum and
antibiotics (penicillin 1Uml1 and streptomycin 10mgml1; all
purchased from PAA Laboratories, Pasching, Austria). The medium
was replaced every 3 days, and cells were split after reaching
confluence. After four passages, cell propagation was performed in
DMEM containing 10% fetal calf serum and penicillin and
streptomycin (DMEM-10).
Growth curves
Cells (1.5 104) were seeded into six-well plates in triplicates, and
DMEM-10 or EGM 2, plus supplement mix (PromoCell, Heidelberg,
Germany) was replaced every 3 days. At different time points, cells
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Figure 2. Behavior of sweat gland–derived stem cells in angiogenic environments. Cells were seeded on polycarbonate (control)- or Matrigel-coated
surfaces. (a) Results show that cells formed capillary-like structures in both DMEM-10 and endothelial growth medium (EGM) (n¼ 3). Moreover, (b) cell
migration (n¼ 9) and (c) proliferation were significantly increased in EGM compared with DMEM-10. Bar¼50 mm in a and 300mm in b. *Po0.05; **Po0.001.
Results are presented as mean±standard error of mean (SEM).
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were trypsinized and counted using an automatic nucleocounter
(NC-100; Chemometec, Allerød, Denmark).
Immunocytochemistry
SGSCs were cultured on two-well chamber slides for 48 hours. Then,
samples were washed twice with phosphate-buffered saline and
fixed in a solution (7:3) of methanol and acetone containing
1mgml1 40,6-diamidino-2-phenylindole (DAPI; Roche, Basel,
Switzerland) for 5minutes at 20 1C, and rinsed three times with
phosphate-buffered saline. Subsequently, samples were blocked in
1.65% normal goat serum (Vector Laboratories, Burlingame,
CA) for 20minutes at room temperature. Primary antibodies against
Oct4 (1:100, polyclonal; Santa Cruz Technology, Santa Cruz, CA),
Nanog (1:2000, polyclonal; Chemicon, Temecula, CA), and
Nestin (1:100, monoclonal; Chemicon) were incubated in a
humid chamber overnight at 4 1C in TBS-T (Tris-buffered saline-
Triton X: 150mM NaCl, 10mM Tris (pH 8.8), 0.05% Triton X)
containing 0.1% bovine serum albumin. Next, samples were
washed three times with phosphate-buffered saline and incubated
with Cy3-labeled anti-mouse IgG (1:500; Dianova, Hamburg,
Germany) or FITC-labeled anti-rabbit IgG (1:500; Dianova) in a
humid chamber for 1 hour at 37 1C. Finally, samples were washed
three times with phosphate-buffered saline, once in aqua dest.,
mounted in Vectashield mounting medium (Vector Laboratories),
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Figure 3. Cell-seeded scaffolds. After seeding in the scaffold, distribution and interaction of the cells were analyzed. A three-dimensional reconstruction
of the seeded scaffold is shown in a. Here, cells are presented in blue (DNA: 40,6-diamidino-2-phenylindole (DAPI)) and red (F-actin: phalloidin) and the
scaffold in green (autofluorescence). (a, left) Homogeneous distribution and direct interaction of sweat gland–derived stem cells (SGSC) to the scaffold
was observed. (b, upper) Cell metabolic activity in the scaffold was evaluated for 14 days by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium
bromide (MTT) assay. Results showed that the seeded scaffolds turn to dark blue in the presence of MTT. Moreover, an increase in metabolic activity was
observed after 14 days in culture (*Po0.05; n¼ 3). After 24 hours, conditioned media were collected, and the presence of several bioactive molecules was
detected. In contrast to non-seeded scaffolds, the medium from SGSC-seeded scaffolds contains: PAI-1, MMP-9, TIMP-1, pentraxin 3 (PTX3), TSP-1, uPA,
VEGF, CD26, angiopoietin (Ang), IGFBP-3, and IL-8. Bar¼ 100mm. Results are presented as mean±standard error of mean (SEM). OD, optical density.
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and analyzed by fluorescence microscopy (Axioscope 2; Zeiss, Jena,
Germany). To evaluate cell morphology, tetramethylrhodamine
isothiocyanate-conjugated phalloidin (Sigma-Aldrich, Taufkirchen,
Germany) was used according to the manufacturer’s instructions.
RNA isolation and reverse-transcriptase–PCR
Total RNA isolation was performed according to the manufacturer’s
instructions using the RNeasy Plus Mini kit (Qiagen, Hilden,
Germany) and the QIAcube for automated RNA isolation including
a genomic DNA removing step. RNA concentration was determined
by measuring the absorbance at 260 nm, using a Nanodrop
spectrophotometer (Peqlab, Erlangen, Germany). Complementary
DNA was synthesized from 500ng of total RNA using the
QuantiTect reverse transcription kit (Qiagen) including a further
genomic DNA digestion step. PCR was carried out with 1ml comple-
mentary DNA in a 25 ml reaction volume using the QuantiFast
SYBR Green PCR kit and commercially available ready-to-use
QuantiTect Primers (all purchased from Qiagen, see Table 1). PCR
was performed using the Mastercycler ep realplex (Eppendorf,
Hamburg, Germany). The amplification cycle included a melting
step (95 1C) and a combined annealing and amplification step
(60 1C). Capillary gel electrophoresis was applied on generated
PCR products in the course of the qualitative characterization of
mRNA expression. To equalize variations in different capillaries,
an alignment marker was implemented in every run, and analysis
was performed using the BioCalculator software 1.0 (Qiagen). To
determine the size of separated DNA fragments, a DNA size marker
was used (Qiagen). Finally, results were shown in gel image format.
Matrigel tube formation assay
A volume of 150ml of Matrigel (BD Bioscience, Bedford, Massachusetts)
was added into each well of a 24-well plate and incubated for 1hour at
37 1C. After gelification, 2.5 104 SGSCs were seeded in each well in
EGM or DMEM-10, and pictures were taken after 5hours. Human
umbilical vein endothelial cells were used as positive control and cells
seeded in polycarbonate as negative control.
Scratch assay
SGSCs (1 104) were seeded in each well of a culture insert (Ibidi,
Martinsried, Germany) in 100ml DMEM-10. Once the cells reached
confluence, inserts were removed and the medium was replaced
with fresh DMEM-10 or EGM (Promocell). After 24 hours, pictures
a b c
Figure 4. Bilateral full skin dermal regeneration model. (a) A 10-mm-diameter bilateral full skin defect was created in the back of the animal. (b) To avoid
contraction of the wound and to minimize artifacts during tissue harvesting, a titanized mesh was placed between the wound bed and the scaffold.
(c) Finally, the wound was covered with a scaffold for dermal regeneration. Lower panel shows the wound area in higher magnifications. Bar¼10mm.
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were taken and cell migration into the gap area (scratch) was
compared and quantified using the TScratch software (Tobias
Geba¨ck & Martin Schulz, ETH, Zu¨rich, Switzerland) as described
before (Geba¨ck et al., 2009). Results were expressed as the
percentage of the original gap surface covered with cells.
Scaffold for dermal regeneration and cell seeding
Integra matrix (Integra LifeScience Corporation, Plainsboro, NJ)
is a scaffold based on bovine collagen fibers crosslinked with
glycosaminoglycans, which forms a porous biodegradable structure.
On top, the collagen structure is covered with a removable silicon
layer, which acts as a temporal epidermis. Pieces of Integra (6 or
12mm diameter) were dried with sterile gauze, and placed in a
24-well plate with the silicon layer facing down. Then, 200ml
of medium containing cells was dropped on each scaffold and
quickly absorbed. After 30minutes of incubation, 1ml of DMEM-10
was added into each well, and the medium was replaced every
2 days. Integra matrix was kindly provided by Integra LifeScience
Corporation.
Cell visualization in the scaffold and three-dimensional
reconstruction
At 48 hours after seeding, scaffolds containing cells were fixed in
3.7% formaldehyde (Sigma-Aldrich) for 30minutes at room tem-
perature. Subsequently, the silicon layer was removed and the
whole scaffold was stained for 1 hour with tetramethylrhodamine
isothiocyanate-conjugated phalloidin (Sigma-Aldrich), used accord-
ing to the manufacturer’s instructions. Finally, samples were
mounted in ProLong Gold antifade reagent containing DAPI
(Invitrogen, Carlsbad, CA) and analyzed in an FV10i confocal
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Figure 5. Vascularization and structure of the scaffolds in vivo. At 2 weeks post transplantation, vascularization levels and the general structure of the
wound were analyzed and compared. (a) A representative picture of each group is shown by transillumination and digital segmentation. Quantification
of the vessel area from control (non-seeded scaffold) and scaffold containing sweat gland–derived stem cells (SGSCs) showed significantly higher vascularization
in the presence of SGSCs. (b) Histological analysis shows that the presence of SGSCs decreased the cellularity levels (40,6-diamidino-2-phenylindole
(DAPI): blue) of the scaffolds (autofluorescence: green), and increased the thickness of the wound bed. Results are representative of eight independent scaffolds
per group. Bar¼200 mm in a and 100mm in b. *Po0.05; **Po0.001. Results are presented as mean±standard error of mean (SEM).
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microscope (Olympus, Hamburg, Germany). Three-dimensional
reconstructions were performed using the Amira software (Visage
Imaging GmbH, Berlin, Germany).
Quantification of metabolic activity in the scaffold
SGSCs (1 105) were seeded in a 6-mm-diameter scaffold. At
different time points, scaffolds were incubated for 1 hour in fresh
medium containing 500mgml1 of MTT (Sigma-Aldrich). Next, the
medium was removed and replaced with 100ml of DMSO (Sigma-
Aldrich). To quantify metabolic activity, absorbance at 560 nm was
measured in the DMSO containing soluble formazan blue. Scaffolds
without cells were used as blank.
Cytokine array profile
SGSCs (5 105) were seeded and cultured in a piece of scaffold
(12mm diameter). After overnight culture, the medium was replaced
with DMEM supplemented with 2% fetal calf serum and maintained
in culture for another 24 hours. Next, the medium was removed
and cytokine release was evaluated using a cytokine protein array
(R&D Systems, Minneapolis, MN), following the manufacturer’s
instructions. Scaffolds without cells, incubated for 24 hours in the
same medium, were used as negative controls.
Scaffold-based dermal regeneration model
Scaffolds obtained from eight athymic nude mice (6–8 weeks old;
Taconic, Copenhagen, Denmark) were analyzed. Animals were
distributed in two groups: four controls (eight empty scaffolds) and
four animals engrafted with scaffolds containing SGSCs (eight cell-
seeded scaffolds). Before transplantation, animals were anes-
thetized with ketamine (10mg kg1) and xylazine (2.4mg kg1) via
intraperitoneal injection. Under general anesthesia, a bilateral full
skin defect was created in the back of the animals (10mm diameter),
and the skin was replaced by control or cell-seeded scaffolds of
12mm diameter (Figure 4). To minimize possible artifacts during
tissue harvesting, a titanized mesh (TIMESH; GfE Medizintechnik
GmbH, Nu¨rnbeg, Germany) was placed between the wound bed
and the scaffolds. Then, scaffolds were fixed to the wound using
non-absorbable sutures, and wounds were bandaged with sterile
gauze. At 2 weeks after transplantation, animals were killed by
overdose of ketamine and xylazine, and the whole skin from the
back, including the scaffolds, was removed for further analysis.
All in vivo procedures were approved by the corresponding local
ethics committees.
Quantification of the vascularization levels
To quantify vascularization levels, tissue transillumination and
digital segmentation were performed as described before (Egan˜a
et al., 2009c). After 2 weeks, skin from the back of the animals
was removed and quickly placed over a transilluminator (LP 5000K;
Hama, Monheim, Germany). Then, digital pictures were obtained in
TIF file format (Olympus camera, C-5060, 5.1megapixels) and
processed for digital segmentation. For quantification, the percen-
tage of the vascularized area was compared with the normal skin of
the same sample (vessel area) and compared among groups. The
vessel analysis software used here can be downloaded for free at
http://www.isip.uni-luebeck.de/index.php?id=150.
Histological analysis
Thereafter, cellularity levels of the scaffolds were quantified by
analyzing DAPI-stained cryosections. Images were acquired with a
Table 1. List of the QuantiTect Primers used for PCR analysis
Primer Target Amplicon length (bp) Catalog number
Nestin Nestin 77 QT00235781
Nanog Nanog 90 QT01025850
Oct4 Octamer binding transcription factor 4 75 QT01664257
Sox2 Sex determining region Y-box 2 64 QT00237601
Klf4 Kruppel-like factor 4 72 QT00061033
cMyc CMyC 129 QT00035406
Ki67 Ki67 86 QT00014203
b3T Beta-3-tubulin 78 QT00083713
PGP9.5 Protein gene product 9.5 134 QT00092666
NF Neurofilament m 74 QT00073885
S100 S100 calcium binding protein B 64 QT00059164
aSMA Alpha smooth muscle actin 83 QT00088102
PPARg Peroxisome proliferator-activated receptor gamma 113 QT00029841
Runx2 Runt-related transcription factor 2 101 QT00020517
Insulin Insulin 98 QT01531040
Albumin Albumin 106 QT00063693
Amylase Amylase 96 QT01680595
vWF von Willebrandt factor 108 QT00051975
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fluorescence microscope (Axioscope 2; Zeiss) equipped with
different filter sets. With the DAPI channel, nucleic staining was
detected, and with the FITC channel, the autofluorescent Integra
matrix could be displayed. Images were obtained using a digital
camera (AxioCam MRc5; Zeiss) with a resolution of 1.3megapixels.
To calculate the number of DAPI-stained nuclei within the matrix, an
image recognition software was used, which automatically detects
the DAPI-stained area, as well as the Integra matrix area (region of
interest), which was defined as a mask. Therefore, a Gaussian
blurring was used to obtain a homogeneous image and to remove
details. Then, the region of interest was calculated using a threshold-
based segmentation. Within these FITC channel masks, cell nuclei
were detected using a threshold-based segmentation. The number
of cells was normalized to the area of the masks; i.e., the number of
cells was calculated in cells per mm2. For these analyses,
representative microscopy images were used (control group,
n¼ 42; SGSC group, n¼ 53). All software development and analysis
of this quantification were performed using MATLAB R2010b
64 bit (MathWorks, Natick, Massachusetts). The histological
analysis also comprised an evaluation of the wound-bed thickness.
Here the area beneath the scaffold was estimated. Wound-bed
thickness was measured in 24 representative microscopical images
per experiment group using the measure tool of the Zeiss Axiovision
software (Carl Zeiss MicroImaging GmbH, Jena, Germany).
Statistical analysis
All assays were repeated in at least three independent experiments.
Data were expressed as mean±SEM. Two-tailed Student’s t-test was
used to compare differences between two groups. The GraphPad
Prism 5 software (GraphPad Software, La Jolla, CA) was used
for statistical analyses. Differences among means were considered
significant when Po0.05.
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